Dr. David Visi Joins SMI
“As a scientist who has spent the last five years working in the public policy arena, David brings a unique and valuable perspective to SMI and to our life science clients,” said SMI COO Bill McCann. “He’ll not only be able to help clients navigate the federal agency landscape but David can also work the halls of Congress.”
“I am excited to be joining SMI’s Life Science team. My focus is to help clients navigate the executive and legislative branch in order to do what they do best – develop new medicines and life-saving technologies to improve patient health,” said Dr. Visi.
Dr. Visi most recently served as an AAAS Science and Technology Policy Fellow at the Department of Defense (DoD) Office of the Deputy Assistant Secretary of Threat Reduction and Arms Control (TRAC). Within TRAC, Dr. Visi provided oversight and program governance on the Defense Threat Reduction Agency Biological Threat Reduction Program (BTRP), which focused on enhancing partner states’ biosecurity, biosafety, and biosurveillance capacity.
Prior to the DoD, Dr. Visi worked on The Pew Charitable Trusts’ Antibiotic Resistance Project on research and policies to advance antibacterial discovery and development, including an analysis of the global development pipeline of antibiotics and nontraditional approaches, BARDA reauthorization, and domestic and global antibiotic regulatory structure.
Dr. Visi also served as a policy advisor on health and agriculture for Congresswoman Louise M. Slaughter.
Dr. Visi has a PhD in molecular biology and biochemistry from the University of North Texas.
Founded in 1993, Strategic Marketing Innovations (SMI) has been the premier choice in Washington for companies, universities, nonprofits, and industry associations seeking enhanced strategies for technology development and enterprise growth. Representing over seventy clients nationwide, SMI combines both lobbying and government affairs support with technical consulting services.